skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > glycotetraosylceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > glycotetraosylceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:0)
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > glycotetraosylceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > glycotetraosylceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:0)
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > glycotetraosylceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > glycotetraosylceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycotetraosylceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:0)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycotetraosylceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycotetraosylceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycotetraosylceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:0)
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycotetraosylceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide > so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:0)

اصطلاح مرجح

so3-3beta-d-galnac-(1->3)-alpha-d-gal-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(d18:0)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • -1

فرمول

  • C45H80N2O26SR

والد-عملکردی دارد

جرم

  • 1097.182

جرم تک‌ایزوتوپی

  • 1096.47200

اسمایلٓ

  • [C@H]([C@@H](CCCCCCCCCCCCCCC)O)(NC(=O)*)CO[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@@H]([C@H](O)[C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@H]([C@@H](O)[C@H](O4)CO)OS(=O)(=O)[O-])NC(C)=O)[C@H]([C@H](O3)CO)O)O)CO)[C@@H]([C@H]1O)O)CO

زیرمجموعه

  • 2_STAR

مترادف مرتبط

  • isogloboside SO3-iGb4Cer (d18:0)
  • SO3-3N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
  • SO3-3N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphinganine
  • SO3iGb4Cer(d18:0)
  • sulfo-Cytolipin R(d18:0)
  • sulfo-iGb4Cer IV3(d18:0)

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:141161

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD